UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

A retrospective study evaluating outcomes of surgical excision versus radiologic follow-up of benign breast papillomas without atypia

The American journal of surgery, 2022-09, Vol.224 (3), p.932-937

2022

Volltextzugriff (PDF)

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance

Proceedings of the National Academy of Sciences - PNAS, 2013-10, Vol.110 (42), p.17041-17046

2013

Volltextzugriff (PDF)

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups

JAMA : the journal of the American Medical Association, 2007-12, Vol.298 (24), p.2869

2007

Volltextzugriff (PDF)

A recurrent mutation in PALB2 in Finnish cancer families

Nature, 2007-03, Vol.446 (7133), p.316-319

2007

Volltextzugriff (PDF)

PALB2 mutations in familial breast and pancreatic cancer

Familial cancer, 2011-06, Vol.10 (2), p.225-231

2011

Volltextzugriff (PDF)

Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients

PloS one, 2019-05, Vol.14 (5), p.e0216997-e0216997

2019

Volltextzugriff (PDF)

Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients

PloS one, 2020-03, Vol.15 (3), p.e0230529-e0230529

2020

Volltextzugriff (PDF)

BRCA1 promoter methylation in sporadic breast tumors : relationship to gene expression profiles

Breast cancer research and treatment, 2005-05, Vol.91 (2), p.179-186

2005

Volltextzugriff (PDF)

Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry

Cancer epidemiology, biomarkers & prevention, 2009-04, Vol.18 (4), p.1084-1091

2009

Volltextzugriff (PDF)

Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells

The Journal of surgical research, 2007-03, Vol.138 (1), p.37-44

2007

Volltextzugriff (PDF)

BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50

Cancer epidemiology, biomarkers & prevention, 2006-10, Vol.15 (10), p.1863-1870

2006

Volltextzugriff (PDF)

BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research

Breast cancer research and treatment, 2009-07, Vol.116 (2), p.379-386

2009

Volltextzugriff (PDF)

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers

Breast cancer research : BCR, 2010-11, Vol.12 (6), p.R95-R95, Article R95

2010

Volltextzugriff (PDF)

Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA Mutations

Cancer epidemiology, biomarkers & prevention, 2006-02, Vol.15 (2), p.359-363

2006

Volltextzugriff (PDF)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Nature communications, 2019-04, Vol.10 (1), p.1741-18, Article 1741

2019

Volltextzugriff (PDF)

Isolation and initial characterization of the BRCA2 promoter

Oncogene, 1999-10, Vol.18 (44), p.6000-6012

1999

Volltextzugriff (PDF)

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

Breast cancer research and treatment, 2013-05, Vol.139 (1), p.193-198

2013

Volltextzugriff (PDF)

Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry

Breast cancer research and treatment, 2015-06, Vol.151 (3), p.653-660

2015

Volltextzugriff (PDF)

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

The American journal of surgical pathology, 2007, Vol.31 (1), p.121-128

2007

Volltextzugriff (PDF)

Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers

The American journal of surgical pathology, 2009-07, Vol.33 (7), p.1093-1097

2009

Volltextzugriff (PDF)

Declining Plasma Fibrinogen Alpha Fragment Identifies HER2-Positive Breast Cancer Patients and Reverts to Normal Levels after Surgery

Journal of proteome research, 2006-11, Vol.5 (11), p.2947-2955

2006

Volltextzugriff (PDF)

Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors: e1003284

PLoS genetics, 2013-03, Vol.9 (3)

2013

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaBreast Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A retrospective study evaluating outcomes of surgical excision versus radiologic follow-up of benign breast papillomas without atypia

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups

A recurrent mutation in PALB2 in Finnish cancer families

PALB2 mutations in familial breast and pancreatic cancer

Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients

Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients

BRCA1 promoter methylation in sporadic breast tumors : relationship to gene expression profiles

Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry

Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells

BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50

BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers

Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA Mutations

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Isolation and initial characterization of the BRCA2 promoter

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers

Declining Plasma Fibrinogen Alpha Fragment Identifies HER2-Positive Breast Cancer Patients and Reverts to Normal Levels after Surgery

Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors: e1003284

Aktive Filter

Suchergebnisse filtern